Antimicrobial resistance among invasive Haemophilus influenzae strains: Results of a Brazilian study carried out from 1996 through 2000

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 11, 2002, Pages 1293-1300

  Casagrande, S T ^a   Landgraf, I M ^a   Kobata, A M M ^a   Zanella, R C ^a   Bokermann, S ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Antimicrobial resistance; Heamophilus influenzae; Meningitis

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRAZIL; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; DRUG CHOICE; DRUG SENSITIVITY; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; TIME;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE SEROTYPE B; NEGIBACTERIA;

EID: 0036863506     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2002001100006     Document Type: Article

References (38)

1. Bluestone CD, Stephenson JM & Martin LM (1992). Ten-year review of otitis media pathogens. Pediatric Infectious Disease Journal, 11: S7-S11.
2. Doern GV, Brueggeman AB, Pierce G, Holley HP & Rauch A (1997). Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrobial Agents and Chemotherapy, 41: 292-297.
3. Booy R & Kroll JS (1997). Is Haemophilus finished? Journal of Antimicrobial Chemotherapy, 40: 149-153.
4. Bisgard KM, Kao A, Leake J, Strebel PM & Wharton M (1998). Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of vaccine-preventable childhood disease. Emerging Infectious Disease, 4: 1-13.
5. Garpenholt O, Silfverdal S & Levin L (1998). Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden. Scandinavian Journal of Infectious Diseases, 30: 5-10.
6. Ministério da Saúde (1998). Meningites em geral. In: Guia de Vigilância Epidemiológica. Fundação Nacional de Saúde, Brasilia, DF, Brazil, Chapter 5.30.
7. Doern GV, Jorgensen JH, Thornsberry C & Preston DA (1986). Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagnostic Microbiology and Infectious Disease, 4: 95-107.
8. Khan W, Ross S, Rodrigues S, Mather LA & Saz AK (1974). Haemophilus influenzae type b resistant to ampicillin: a report of two cases. Journal of the American Medical Association, 229: 298-301.
9. Tomeh MO, Starr SE, McGowan JE, Terry PM & Nahmias AJ (1974). Ampicillin-resistant Haemophilus influenzae type b infection, Journal of the American Medical Association, 229: 295-297.
10. Sykes RB & Mathew M (1978). Methods for detecting beta-lactamase. In: Reeves DS, Phillips JD, Williams JD & Were R (Editors), Laboratory Methods in Antimicrobial Chemotherapy. Churchill Livingstone, Edinburgh, UK, 64-69.
11. Mardowitz SM (1980). Isolation of an ampicillin-resistant, non-β-lactamase-producing strain of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy, 17: 80-83.
12. Jorgensen JH, Doern GV, Maher LA, Howell AW & Redding JS (1990). Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy, 34: 2075-2080.
13. Scriver SR, Walmsley SL, Kau CL, Hoban DJ, Brunton J, McGrer A, Moore TC & Witwicki E (1994). Determination of antimicrobial susceptibility of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamase. Canadian Haemophilus Study Group, Antimicrobial Agents and Chemotherapy, 38: 1678-1680.
14. Manninen R, Houvinen P, Nissinen A & The Finnish Study Group for Antimicrobial Resistance (1997). Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland. Journal of Antimicrobial Chemotherapy, 40: 387-392.
15. Kilian M & Biberstein EL (1984). Haemophilus. In: Krieg NR & Holt JG (Editors), Bergey's Manual of Systematic Bacteriology. 8th edn. Baltimore, MD, USA, 558-569.
16. Pitman M (1931). Variation and type specificity in the bacterial species Haemophilus influenzae. Journal of Experimental Medicine, 53: 471-492.
17. National Committee for Clinical Laboratory Standards (NCCLS) (1999). Performance Standards for Antimicrobial Susceptibility Testing: Ninth Informational Supplement M100-S9. National Committee for Clinical Laboratory Standards, Villanova, PA, USA.
18. Rey LC & Farhat CK (1997). Prevalência de Haemophilus influenzae resistente a ampicilina, cefaclor, cefotaxime, cloranfenicol e cotrimozaxol isolados de laboratórios na cidade de São Paulo. Jornal de Pediatria, 73: 26-31.
19. Casagrande ST, Vicente EJ, Landgraf IM & Kobata AMM (2000). Antimicrobial resistance patterns of Haemophilus influenzae isolated from patients with meningitis in São Paulo, Brazil. Brazilian Journal of Medical and Biological Research, 33: 295-300.
20. Critchley IA, Thornsberry C, Piazzat G, Jones M, Hichey ML, Barth AL, Mendes C, Rossi FF, Sader HS, Teixeira LM & Sahm DF (2000). Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98. Clinical Microbiology and Infectious Diseases, 6: 178-184.
21. Sader HS, Gales AC, Granacher TD, Pfaller MA, Jones RN and The SENTRY Study Group (Latin America) (2000). Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: Results from SENTRY antimicrobial surveillance program (1997-98). Brazilian Journal of Infectious Diseases, 4: 245-254.
22. Goldstein FW & Acar JF (1995). Epidemiology of antibiotic resistance in Haemophilus influenzae. Microbial Drug Resistance, 1: 131-135.
23. Brunton J, Clare D & Meire MA (1986). Molecular epidemiology of antibiotic resistance plasmids of Haemophilus species and Neisseria gonorrhoeae. Reviews of Infectious Diseases, 8: 713-724.
24. James PA, Lewis DA, Jordens JZ, Cribb J, Dawson SJ & Murray AS (1996). The incidence and epidemiology of β-lactam resistance in Haemophilus influenzae. Journal of Antimicrobial Chemotherapy, 37: 737-746.
25. Thornsberry C, Ogilvie PT, Holley HP & Sahm DF (1999). Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrobial Agents and Chemotherapy, 43: 2612-2623.
26. Johnson AW, Mookkolu AO & Onile BA (1992). Chloramphenicol-resistant Haemophilus influenzae meningitis in young urban Nigerian children. Acta Paediatrica, 81: 941-943.
27. Baquero F & Task Force of the General Direction for Health Planning of the Spanish Ministery of Health (1996). Antibiotic resistance in Spain: What can be done? Clinical Infectious Diseases, 23: 819-823.
28. IBGE: Brazilian Institute of Geography and Statistics, Available at Accessed August 24, 2001.
29. Richet HM, Mohammed J, McDonald LC, Jarvis WR & International Network for the Study and Prevention of Emerging Antimicrobial Resistance (2001). Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerging Infectious Diseases, 7: 319-322.
30. Cookson B, Johnson AP, Azaidan B, Paul G, Hutchinson G, Kaufmann M, Woodford N, Malde M, Walsh B, Yousef A & Selkon J (1995). International inter- and intra-hospital patient spread of a multiple antibiotic-resistant strain of Klebsiella pneumoniae. Journal of Infectious Diseases, 171: 511-513.
31. Camargo MCC (1996). Doença meningocócica no município de São Paulo, no período de 1979 a 1993 endemia e epidemia. Master's thesis, Faculdade de Saúde Pública, USP, São Paulo, SP, Brazil.
32. Campos J, Torne SG, Gain JMJ & Fabregues I (1986). Multiple resistant Haemophilus influenzae type b causing meningitis: Comparative clinical and laboratory study. Journal of Pediatrics, 108: 897-902.
33. Brandileone MCC, Di Fabio JL, Vieira VSD, Zanella RC, Casagrande ST, Pignatari AC & Tomasz A (1998). Geographic distribution of penicillin resistance of Streptococcus pneumoniae in Brazil: genetic relatedness. Microbial Drug Resistance, 4: 209-217.
34. Klugman KP & Madhi SA (1999). Emergence of drug resistance: impact on bacterial meningitis. Infectious Diseases Clinics of North America, 13: 637-646.
35. Ministério da Saúde (1998). Meningite por Haemophilus influenzae. In: Guia de Vigilância Epidemiológica. Fundação Nacional de Saúde, Brasília, DF, Brazil, Chapter 5.21.
36. Clairoux N, Picard M, Brochu A, Rousseau N, Gourde P, Beauchamp D, Parr Jr TR, Bergeron MG & Malouin F (1992). Molecular basis of the non-β-lactamase-mediated resistance to β-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrobial Agents and Chemotherapy, 36: 1504-1513.
37. Woolfrey BF, Lally RT & Ederer MN (1987). Evaluation of Haemophilus influenzae type b systemic isolates for β-lactamase and non-β-lactamase mediated ampicillin resistance and for susceptibility to other antimicrobials. American Journal of Clinical Pathology, 88: 361-365.
38. Richet HM (2001). Better antimicrobial resistance surveillance efforts are needed. American Society for Microbiology, 67: 304-309.